Projects per year
Personal profile
Education
- 2002-2007 Postdoctoral training in Hematology and Oncology, Mount Sinai School of Medicine, New York, USA
- 1997.09-2002.05 Ph.D., in Biology, City University of New York, USA
- 1994.09-1997.07 M.S., in Biology, City University of New York , USA
- 1984.09-1988.06 B.S., Department of Plant Pathology, National Chung Hsing University
Experience
- 2018.02- Associate Professor, International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University
- 2018.02- Associate Professor, International Ph.D. Program for Cell Therapy and Regeneration Medicine, Taipei Medical University
- 2016.11-2017.10 Associate Professor, International Master/Ph.D. Program in Medicine, College of Medicine, Taipei Medical University
- 2013.02- Associate Professor, Graduate Institute of Medical Sciences, Taipei Medical University
- 2009.08-2013.07 Assistant Professor, Graduate Institute of Medical Sciences, Taipei Medical University
- 2009.02-2009.07 Assistant Professor, Institute of Microbiology & Immunology, Chung Shan Medical University
- 2007.10-2008.10 Research Associate, Hematology and Oncology/Medicine, Mount Sinai School of Medicine, New York, USA
- 1994-2008 Postdoctoral Fellow, Hematology and Oncology/Medicine, Mount Sinai School of Medicine, New York, USA
- 1994-2001 Adjunct Lecturer, Biology, Queens College, City University of New York
Awards
- 2007 Travel Award, ASH 50th Annual Meeting, San Diego, CA
Research Interests
- Leukocyte trafficking, Cancer biology, Wound healing, Traumatic brain injury
Fingerprint
Dive into the research topics where Jungshan Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 16 Finished
-
The Oncogenic Role and Targeted Therapeutic Potential of Alpha 9 Nicotinic Acetylcholine Receptors on Breast Cancers: Emphasizing in Pre-Clinical Assessment of Biphasic Antibody Nano-Drugs in Xenografts( III )
8/1/19 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
The Oncogenic Role and Targeted Therapeutic Potential of Alpha 9 Nicotinic Acetylcholine Receptors on Breast Cancers: Emphasizing in Pre-Clinical Assessment of Biphasic Antibody Nano-Drugs in Xenografts(II)(2/3)
8/1/18 → 8/1/19
Project: A - Government Institution › b - National Science and Technology Council
-
The Oncogenic Role and Targeted Therapeutic Potential of Alpha 9 Nicotinic Acetylcholine Receptors on Breast Cancers: Emphasizing in Pre-Clinical Assessment of Biphasic Antibody Nano-Drugs in Xenografts( I )
8/1/17 → 7/31/18
Project: A - Government Institution › b - National Science and Technology Council
-
Characterizing the Therapeutic Roles of Depleting Brain-Infiltrated Leukocytes Using Pan-Selectin Antagonist and Intravenous Immunoglobulins in Traumatic Brain Injury
8/1/15 → 7/31/16
Project: A - Government Institution › b - National Science and Technology Council
-
以MALDI與TOF-SIMS研究大腸癌病人血液與組織內CTGF與PTEN表現探討
6/1/14 → 5/31/16
Project: C - Project of Alliance › t - Taipei Municipal Wanfang Hospital
-
Radiotherapy enhances CXCR3highCD8+ T cell activation through inducing IFNγ-mediated CXCL10 and ICAM-1 expression in lung cancer cells
Wang, C. L., Ho, A. S., Chang, C. C., Sie, Z. L., Peng, C. L., Chang, J. & Cheng, C. C., 2023, (Accepted/In press) In: Cancer Immunology, Immunotherapy.Research output: Contribution to journal › Article › peer-review
Open Access -
Airway Exposure to 1,3-Beta-d-Glucan Induces Airway Hyperresponsiveness in Guinea Pigs
Lin, Y. S., Chen, Y. Y., Chan, N. J., Chang, J., Li, S. S. & Hsu, C. C., Mar 11 2022, In: ACS Pharmacology and Translational Science. 5, 3, p. 169-175 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Caffeic Acid Phenethyl Ester Inhibits Basal Lipolysis by Activating PPAR-Gamma and Increasing Lipid Droplet-Associated Perilipin in Mature Rat Adipocytes
Trang, N. T. T., Chiu, W. C., Feng, Y. T., Hsieh, S. L., Tung, D. D., Chang, J. & Fong, T. H., 2022, In: Evidence-based Complementary and Alternative Medicine. 2022, 6007233.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Combined impacts of histamine receptor H1 gene polymorphisms and an environmental carcinogen on the susceptibility to and progression of oral squamous cell carcinoma
Ding, Y. F., Lin, Y. W., Chiu, W. K., Lin, C. W., Yang, Y. C., Chang, L. C., Chang, J., Yang, S. F. & Chien, M. H., 2022, In: Aging. 14, 10, p. 4500-4512 13 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Improving Tirapazamine (TPZ) to Target and Eradicate Hypoxia Tumors by Gold Nanoparticle Carriers
Ajnai, G., Cheng, C. C., Kan, T. C., Lu, J. W., Rahayu, S., Chiu, A. & Chang, J., Apr 2022, In: Pharmaceutics. 14, 4, 847.Research output: Contribution to journal › Article › peer-review
Open Access5 Citations (Scopus)
Datasets
-
Additional file 3: of STAT3 exacerbates survival of cancer stem-like tumorspheres in EGFR-positive colorectal cancers: RNAseq analysis and therapeutic screening
Chang, Y. (Creator), Ho, A. (Contributor), Yang, B. (Contributor), Chang, J. (Creator), Chiang, Y. (Creator), Chen, C. G. (Creator), Chang, C. (Creator), Lin, H. (Contributor), Su, Y. (Creator), Cheng, C. (Contributor), Chang, Y. (Creator), Liao, P. (Contributor) & Lim, K. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.6891197.v1, https://doi.org/10.6084%2Fm9.figshare.6891197.v1
Dataset
-
MOESM8 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Lim, K. (Contributor), Chiang, Y. (Creator), Sie, Z. (Creator), Chang, J. (Creator), Chang, Y. (Creator), Ho, A. (Contributor) & Cheng, C. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.9993593.v1, https://doi.org/10.6084%2Fm9.figshare.9993593.v1
Dataset
-
MOESM4 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Cheng, C. (Contributor), Sie, Z. (Creator), Lim, K. (Contributor), Chang, J. (Creator), Chiang, Y. (Creator), Chang, Y. (Creator) & Ho, A. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.9993569.v1, https://doi.org/10.6084%2Fm9.figshare.9993569.v1
Dataset
-
MOESM6 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Chang, Y. (Creator), Chiang, Y. (Creator), Lim, K. (Contributor), Cheng, C. (Contributor), Ho, A. (Contributor), Chang, J. (Creator) & Sie, Z. (Creator), Figshare, 2019
DOI: 10.6084/m9.figshare.9993584.v1, https://doi.org/10.6084%2Fm9.figshare.9993584.v1
Dataset
-
MOESM10 of STAT3 induces G9a to exacerbate HER3 expression for the survival of epidermal growth factor receptor-tyrosine kinase inhibitors in lung cancers
Chiang, Y. (Creator), Lim, K. (Contributor), Sie, Z. (Creator), Chang, Y. (Creator), Chang, J. (Creator), Ho, A. (Contributor) & Cheng, C. (Contributor), Figshare, 2019
DOI: 10.6084/m9.figshare.9993536.v1, https://doi.org/10.6084%2Fm9.figshare.9993536.v1
Dataset